RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 66 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.9%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,534,220 | $4,206,805 | 51.67% |
| BML Capital Management, LLC | 2,177,913 | $3,615,336 | 2.38% |
| Aldebaran Capital, LLC | 396,410 | $658,041 | 0.63% |
| TANG CAPITAL MANAGEMENT LLC | 2,997,000 | $4,975,020 | 0.52% |
| Aisling Capital Management LP | 886,075 | $1,470,885 | 0.50% |
| NEA Management Company, LLC | 4,785,494 | $7,943,920 | 0.49% |
| Octagon Capital Advisors LP | 2,250,000 | $3,735,000 | 0.45% |
| Acuitas Investments, LLC | 404,048 | $670,720 | 0.34% |
| Carlyle Group Inc. | 2,698,957 | $4,453,279 | 0.28% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,736,570 | $4,542,706 | 0.17% |